ELIXIR-UK is pleased to announce the appointment of Gabriella Rustici as its new Deputy Head of Node. Dr Rustici is Bioinformatics Training Manager for the School of Biological Sciences of the University of Cambridge and leads on developing standards and best-practice guidelines for the assessment of training quality and impact within ELIXIR-UK. She will take the lead on building the ELIXIR-UK community as well as working closely with Carole Goble (Head of Node) and John Hancock (Node Coordinator) in the day-to-day running of the Node. For more detail about Gabriella see http://www.elixir-uk.info/team/gabriella-rustici.

Dear colleagues, I’m contacting you on behalf of the EU project CORBEL to which your research infrastructure / your institute is a partner.

The Open Call for Research Projects, organised by WP4, will be launched on October 5, 2016; selected researchers will then have the unique opportunity to gain open access to state-of-the-art technologies and services offered by these research infrastructures across biological and medical sciences.

In order to distribute this news to a broad audience, we would like to ask for your support:

I would like to ask whether it is possible to place the attached announcement on your website. In addition to the plain text, we also prepared an animated GIF/an Apply-Now button to attract the reader.Would it be possible to also add one or both figures to your website?

It would be nice if the announcement could be presented on your website until end of November (call deadline: November 30).

Timeline

ELIXIR UK has in place a Collaboration Agreement with the ELIXIR Hub.

The prerequisite of this is that the Earlham Institute, the Head of Node and Manchester University have signed the Warranties Annex that accompanies the Collaboration Agreement.

Via the Collaboration Agreement the UK Node formally becomes part of ELIXIR and can receive funds via Commissioned Service Contracts, Implementation Studies and other instruments

The Node has completed its Node Consortium Agreement and is awaiting sign off from the ELIXIR Hub.

Key Responsibilities of Signatories

  • Confirm that as a Consortium member they wish to collaborate to deliver ELIXIR by fulfilling their role as a constituent part of ELIXIR-UK. This does not imply any financial commitment.
  • Recognise that the Earlham Institute (the Lead Entity) and the Head of Node will enter into the Collaboration Agreement (CA) and its Warranties Annex on behalf of ELIXIR-UK (see Figure 1) and carry out all the resultant obligations, including:

The ELIXIR-UK Node Consortium Agreement

  1. ELIXIR-UK is currently undergoing reorganisation to give it a legal structure compatible with ELIXIR’s requirements. This will enable it to be formally recognised by ELIXIR as a Node.
  2. ELIXIR-UK will in future be formed of a networked consortium bound together by a Node Consortium Agreement (NCA).
  3. The relationship of the NCA to other documents required to establish the Node formally are summarised in Figure 1:

     

Benefits of being part of ELIXIR

  1. ELIXIR is seen as a high-status international activity.
    1. It was prioritised by the EU Competitiveness Council alongside the European Plate Observing System (EPOS) and the European Spallation Source (ESS) and identified as a Landmark in the 2016 ESFRI roadmap.

    2. The G7's Group of Senior Officials has categorised ELIXIR as an infrastructure of global potential.

Key points about ELIXIR and the ELIXIR-UK Consortium

  1. ELIXIR is an intergovernmental organisation (NOT an EU body) that has the remit to provide integrated life science data across Europe and beyond.
  2. ELIXIR is formally a special project of the EMBL (European Molecular Biology Laboratory).
  3. The UK formally joined ELIXIR in September 2013.

Pages